Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.89 - $1.39 $19,135 - $29,886
-21,501 Reduced 18.66%
93,725 $110,000
Q1 2023

May 15, 2023

SELL
$1.06 - $3.05 $83,605 - $240,562
-78,873 Reduced 40.64%
115,226 $129,000
Q4 2022

Feb 14, 2023

SELL
$0.56 - $2.61 $83,931 - $391,178
-149,877 Reduced 43.57%
194,099 $365,000
Q3 2022

Nov 14, 2022

SELL
$0.97 - $1.81 $337,414 - $629,608
-347,850 Reduced 50.28%
343,976 $341,000
Q2 2022

Aug 15, 2022

BUY
$1.13 - $2.66 $342,597 - $806,469
303,184 Added 78.01%
691,826 $996,000
Q1 2022

May 16, 2022

BUY
$1.68 - $5.01 $100,445 - $299,542
59,789 Added 18.18%
388,642 $855,000
Q4 2021

Feb 14, 2022

BUY
$4.02 - $16.84 $422,228 - $1.77 Million
105,032 Added 46.93%
328,853 $1.49 Million
Q3 2021

Nov 15, 2021

BUY
$9.26 - $31.31 $2.07 Million - $7.01 Million
223,821 New
223,821 $3.53 Million
Q2 2021

Aug 16, 2021

SELL
$9.37 - $12.12 $143,389 - $185,472
-15,303 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$10.61 - $15.77 $326,522 - $485,321
-30,775 Reduced 66.79%
15,303 $169,000
Q4 2020

Feb 16, 2021

BUY
$10.21 - $17.31 $341,677 - $579,279
33,465 Added 265.32%
46,078 $562,000
Q3 2020

Nov 16, 2020

SELL
$9.99 - $16.13 $407,432 - $657,845
-40,784 Reduced 76.38%
12,613 $168,000
Q2 2020

Aug 14, 2020

BUY
$11.21 - $18.15 $598,580 - $969,155
53,397 New
53,397 $805,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $66.6M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.